Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
This grant funds research aimed at advancing the understanding and application of precision probiotic therapies.
About this program
The Enhancing Mechanistic Research on Precision Probiotic Therapies grant supports innovative research projects that explore the mechanisms underlying probiotic therapies tailored to individual needs. This funding opportunity is designed for researchers in the healthcare and biomedical fields who are interested in developing and testing precision probiotic interventions. The grant encourages the integration of mechanistic studies with clinical trials to enhance the efficacy and safety of probiotic treatments. Eligible applicants include academic institutions, nonprofit organizations, and small businesses engaged in healthcare research. The grant aims to foster collaboration among researchers, clinicians, and industry partners to translate findings into practical applications. By funding projects that investigate the biological mechanisms of probiotics, the grant seeks to improve health outcomes and contribute to the growing field of personalized medicine.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and small businesses engaged in healthcare research.